Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

New Research Presented At EHA Congress Shows That Soliris(R) Significantly Reduced Hemolysis In Never-Transfused Patients With PNH
Clinical investigators observed that Soliris® (eculizumab), a first-in-class terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), reduced hemolysis (red blood cell destruction) and improved symptoms in nine patients with paroxysmal nocturnal hemoglobinuria (PNH) who had received no blood transfusions prior to initiating Soliris therapy.
generic viagra online
Donors To Reevaluate Support For Myanmar's Fight Against HIV/AIDS
The AP/KTVZ.com examines how after years of strained relationships between the "military-run nation" of Myanmar and international donors that led to a large reduction in HIV/AIDS funding, donors are considering reinvesting in the country"s HIV/AIDS programs. According to AP/KTVZ.com, "Myanmar receives only about $3 per capita in aid, compared with $23 for Vietnam and $50 for Laos."
News of the day
Divisions Plague Dems As Obama Recruits New Allies, Governors
"Four divisive issues could dash President Barack Obama"s hopes of overhauling health care: cost, creating a government-run plan, taxing workers" benefits and penalizing employers that don"t offer coverage," the Associated Press/Boston Globe reports.
Oncology

Increased Occurrences Of Parasomnia Symptoms Experienced By Obstructive Sleep Apnea Patients

Patients suffering from obstructive sleep apnea (OSA) have an increased prevalence of parasomnia symptoms compared with the prevalence rates of individual parasomnias, according to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies. Results indicate that the frequency of parasomnia symptoms in individuals with OSA was 9.5 percent, compared to the 2.9 to 4 percent prevalence of parasomnias in adults older than 15 years of age without OSA. Twenty percent of the study"s participants reported an improvement of their parasomnia symptoms with use of continuous positive airway pressure (CPAP) therapy. According to lead author Maria Viola-Saltzman, DO, at the University of Washington in Seattle, OSA is known to cause sleep fragmentation, which predisposes patients to the expression of parasomnia symptoms. "We found it interesting that the parasomnia symptoms reported in this patient population were amongst all age groups, as parasomnias are most common in children and young adults," said Viola-Saltzman. The study was based on retrospective chart reviews of 537 new patient referrals for evaluation of OSA at Loyola University Medical Center in Chicago. Patients were at least 18 years of age, had a polysomnogram diagnostic of OSA and documentation of the presence or absence of parasomnia symptoms. Fifty-one patients (59 percent women, 84 percent of non-Hispanic origin and average age of 47 years) had one or more types of parasomnia complaints. Twenty-one people (38 percent) reported sleep paralysis, 16 (29 percent) reported sleep-related hallucinations, 11 (20 percent) reported acting-out dreams (suggesting REM sleep behavior disorder), five (9 percent) reported sleepwalking, one person reported sleep-related eating and one person felt a "pulling down sensation" on her spine at sleep onset. Abstract Title: The Frequency of Parasomnia Symptoms in Patients with Obstructive Sleep Apnea Presentation Date: Tuesday, June 9 Category: Sleep Disorders - Breathing Abstract ID: 0600 Kelly Wagner American Academy of Sleep Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009